Chronic Obstructive Pulmonary Disease Phenotypes
Top Cited Papers
- 1 September 2010
- journal article
- other
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 182 (5) , 598-604
- https://doi.org/10.1164/rccm.200912-1843cc
Abstract
Significant heterogeneity of clinical presentation and disease progression exists within chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this heterogeneity, a clear alternative has not emerged. The goal of phenotyping is to identify patient groups with unique prognostic or therapeutic characteristics, but significant variation and confusion surrounds use of the term “phenotype” in COPD. Phenotype classically refers to any observable characteristic of an organism, and up until now, multiple disease characteristics have been termed COPD phenotypes. We, however, propose the following variation on this definition: “a single or combination of disease attributes that describe differences between individuals with COPD as they relate to clinically meaningful outcomes (symptoms, exacerbations, response to therapy, rate of disease progression, or death).” This more focused definition allows for classification of patients into distinct prognostic and therapeutic subgroups for both clinical and research purposes. Ideally, individuals sharing a unique phenotype would also ultimately be determined to have a similar underlying biologic or physiologic mechanism(s) to guide the development of therapy where possible. It follows that any proposed phenotype, whether defined by symptoms, radiography, physiology, or cellular or molecular fingerprint will require an iterative validation process in which “candidate” phenotypes are identified before their relevance to clinical outcome is determined. Although this schema represents an ideal construct, we acknowledge any phenotype may be etiologicaxlly heterogeneous and that any one individual may manifest multiple phenotypes. We have much yet to learn, but establishing a common language for future research will facilitate our understanding and management of the complexity implicit to this disease.Keywords
This publication has 64 references indexed in Scilit:
- Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigationRespiratory Research, 2010
- Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypesJournal of Biomedical Informatics, 2009
- The Influence of Radiographic Phenotype and Smoking Status on Peripheral Blood Biomarker Patterns in Chronic Obstructive Pulmonary DiseasePLOS ONE, 2009
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008
- Gender and Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Exacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression?Proceedings of the American Thoracic Society, 2007
- The SAFE (SGRQ score, air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary diseasePostgraduate Medical Journal, 2007
- Profiling serum biomarkers in patients with COPD: associations with clinical parametersThorax, 2007
- Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary DiseasePharmacoEconomics, 2005
- The Diffusing Capacity as a Predictor of Arterial Oxygen Desaturation during Exercise in Patients with Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1984